Revolutions Medical Corporation Receives Up to 10 Million Dollars in Financing

Business Wire, June 24, 2009

MOUNT PLEASANT, S.C. -- Revolutions Medical Corporation--(OTCBB: RMCP News) has just secured financing through a 10 million dollar equity purchase agreement. Revolutions Medical can draw down on this equity line for up to two years at 8% discount to market price. The equity purchase agreement was arranged through Southridge Investment Group, LLC.

Ron Wheet, CEO of Revolutions Medical Corp states “We now have the access to capital we need to execute our business plan and bring our proprietary products to the market place. Shortly, we will be naming our manufacturer and going into production of our 3cc RevVac Safety Syringe, getting our Color and 3D MRI software technology ready for introduction at the RSNA show in Chicago, IL in late fall 2009, and moving forward with our new Breast Biopsy Localization System. Rev Med is now ready to go from just a research and development company, to a leading innovative product driven company with a suite of proprietary technologies to follow.”

Revolutions Medical would also like to thank and acknowledge Wakabayashi Fund, LLC for facilitating this private equity financing. Wakabayashi Fund, LLC is a private equity and consulting firm with offices in New York and Tokyo.

About Southridge Investment Group LLC

Southridge Investment Group LLC is a full service FINRA/SIPC registered broker dealer and investment banking firm authorized to do business in all 50 states. The investment banking practice focuses on the sponsorship needs of small, medium and emerging growth companies as well as the needs of both institutional and individual investors interested in that segment of the market. The firm offers a full range of corporate finance services, including underwritings, M & A, financial advisory, valuations and private placements. The firm can also provide full service brokerage and trading services to individuals and corporate clients. For more information please visit www.southridgegroup.com.

For more information please go to www.revolutionsmedical.com or contact investor relations at 843-408-6265.

Safe Harbor

Forward-looking statements made in this release are made pursuant to the "safe-harbor" provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made by Revolutions Medical Corporation are not a guarantee of future performance. This news release includes forward- looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty.

Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Revolutions Medical Corporation, and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete projects, and changes in products and competition.